Archive > Volume 28 Issue 10 > 2021,28(10):1029-1036 Prev Next

Review

Progress in clinical trials of PD-1/PD-L1 immune checkpoint inhibitors in the treatment of hepatocellular carcinoma

您是第位访问者
Chinese Journal Of Cancer Biotheray ® 2025 All Rights Reserved
Supported by:Beijing E-Tiller Technology Development Co., Ltd.